节点文献

运用甲钴胺联合前列地尔治疗糖尿病周围神经病变的临床观察与疗效分析

Using a Cobalt Amine United Front,For the Treatment of Diabetic Peripheral Neuropathy Clinical Observations and Curative Effect Analysis

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 王毓

【Author】 WANG Yu;Department of Geriatrics,the People’s Hospital of Hegang City;

【机构】 鹤岗市人民医院老年病科

【摘要】 目的通过观察糖尿病周围神经病变(diabetic peripheral neuropathy,DPN)的临床治疗方法 ,探讨运用甲钴胺联合前列地尔治疗糖尿病周围神经病变的疗效。方法选择该院收治的60例糖尿病周围神经病变患者,根据住院时间随机分为对照组和实验组,每组30例,对照组仅使用甲钴胺进行治疗。实验组采用甲钴胺联合前列地尔进行治疗,治疗后比较两组差异。结果治疗后实验组患者有效率为92.3%,对照组有效率为71.3%,实验组明显高于对照组,差异有统计学意义(P<0.05),运用甲钴胺联合前列地尔治疗糖尿病周围神经病有显著疗效,安全系数高,不良反应明显减少,可有效改善和提高糖尿病周围神经病患者的生活质量。结论经过临床研究进行论证,在运用甲钴胺联合前列地尔治疗糖尿病周围神经病过程中,将两种药物联合使用后,两种药物协同作用于机体实现了改善并恢复糖尿病周围神经病变的功能。相比较于单独应用一种药物治疗的方式,显著疗效,安全系数高,不良反应明显减少,为临床中治疗糖尿病周围神经病变疾病提供了有力的依据。

【Abstract】 Objective To observe diabetic peripheral neuropathy(diabetic peripheral neuropathy, DPN) clinical treatment methods to explore the use of Mecobalamin alprostadil therapy of diabetic peripheral neuropathy. Methods 60 patients admitted to our hospital with diabetic peripheral neuropathy patients, based on length of stay were randomly divided into control and experimental groups of 30 patients in the control group using only mecobalamin treatment. The experimental group Mecobalamin alprostadil treatment, the difference between the two groups after treatment. Results After treatment, patients in the experimental group effective rate was 92.3%, the effective rate was 71.3% in the control group, the experimental group was significantly higher, the difference was statistically significant(P<0.05), using Mecobalamin alprostadil treatment of diabetes peripheral neuropathy has a significant effect, high safety factor, significantly reduced adverse reactions, which can effectively improve and enhance the quality of life in patients with diabetic peripheral neuropathy. Conclusion Through clinical research, the use of a united front to cobalt amine in the process of the treatment of diabetic peripheral neuropathy,after two drugs used in combination, the two drugs synergy in the body to achieve the improvement and restore the function of diabetic peripheral neuropathy. Compared with single application of a form of drug treatment, remarkable curative effect,high safety coefficient, less adverse reaction, for the clinical treatment of diabetic peripheral neuropathy disease provided the powerful basis.

【关键词】 甲钴胺前列地尔糖尿病周围神经病变
【Key words】 DiabeticPeripheralNeuropathy
  • 【文献出处】 糖尿病新世界 ,Diabetes New World , 编辑部邮箱 ,2015年17期
  • 【分类号】R587.2
  • 【被引频次】3
  • 【下载频次】26
节点文献中: 

本文链接的文献网络图示:

本文的引文网络